Crestchem Ltd
₹86.16
(-4.90%)
Wed, 18 Mar 2026, 02:14 am
Crestchem Ratios
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 5.20 | 33.45 | 0 | 0 | 0 | 7.44 | 13.69 | 21.69 | 52.97 | 15.94 | 22.73 |
| Price to book ratio | 0 | 0 | 0 | 6.92 | 9.27 | 3.48 | 2.91 | 4.46 | 5.82 | 9.32 | 3.59 | 5.27 | 5.97 | 13.34 | 6.98 | 8.29 |
| Price to sales ratio | 0 | 0 | 0 | 34 | 9.05 | 33.53 | 78.66 | 26.62 | 72.26 | 42.39 | 0.53 | 1.03 | 1.55 | 2.20 | 1.62 | 2.48 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 44.85 | 18.87 | 0 | 0 | 0 | 5.31 | 0 | 9.93 | 14.10 | 57.58 | 31.32 |
| Enterprise value | 0 | 0 | 0 | 31.9M | 41.93M | 21.94M | 25.28M | 32.21M | 35.73M | 44.09M | 26.77M | 75.13M | 125.57M | 358.63M | 340.7M | 612.48M |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 88.25 | 0 | 0 | 0 | 0 | 0 | 4.70 | 11.40 | 16.58 | 42.90 | 12.29 | 18.65 |
| Debt to equity ratio | 0.34 | 0.39 | 0.58 | 0.51 | 1.51 | 0.40 | 0.35 | 0.71 | 0.22 | 0.60 | 0.02 | 0.42 | 0.13 | 0 | 0 | 0 |
| Return on equity % | 0 | -17.58 | 8.38 | -16.87 | -6.17 | 92.53 | 8.94 | -17.61 | -26.13 | -30.33 | 63.73 | 47.63 | 31.94 | 28.82 | 56.09 | 44.06 |
Crestchem Ltd Ratios
The Crestchem Ltd Ratios page provides a complete fundamental analysis of Crestchem Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Crestchem Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Crestchem Ltd (NSE: , BSE: 526269) is currently trading at ₹86.16, with a market capitalization of ₹271.8M. As a major player in the Health technology sector and Pharmaceuticals: other industry, Crestchem Ltd remains a key stock for fundamental analysis using Crestchem Ltd Ratios.
Crestchem Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Crestchem Ltd P/E ratio currently stands at 22.73, making it one of the most tracked metrics in Crestchem Ltd Ratios.
Historically, the Crestchem Ltd P/E ratio has shown strong fluctuations:
- 2024: 22.73
- 2023: 15.94
- 2022: 52.97
- 2021: 21.69
- 2020: 13.69
The rising Crestchem Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Crestchem Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 8.29.
Historical P/B trend:
- 2024: 8.29
- 2023: 6.98
- 2022: 13.34
- 2021: 5.97
Crestchem Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The Crestchem Ltd P/S ratio currently stands at 2.48, an important part of Crestchem Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 2.48
- 2023: 1.62
- 2022: 2.20
- 2021: 1.55
The rising Crestchem Ltd P/S ratio indicates improved revenue valuation by investors.
Crestchem Ltd Price to Cash Flow Ratio (P/CF)
The Crestchem Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 31.32.
Historical Crestchem Ltd Price to Cash Flow Ratio:
- 2024: 31.32
- 2023: 57.58
- 2022: 14.10
- 2021: 9.93
- 2020: 0
The declining Crestchem Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Crestchem Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Crestchem Ltd EV currently stands at ₹612.48M, representing the total company valuation including debt.
Historical EV trend:
- 2024: 612.48M
- 2023: 340.7M
- 2022: 358.63M
- 2021: 125.57M
Crestchem Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Crestchem Ltd EV/EBITDA ratio is currently 18.65, a key metric in Crestchem Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 18.65
- 2023: 12.29
- 2022: 42.90
- 2021: 16.58
Higher Crestchem Ltd EV/EBITDA suggests premium valuation.
Crestchem Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Crestchem Ltd D/E ratio is currently 0, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0.13
Crestchem Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Crestchem Ltd ROE currently stands at 44.06%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 44.06
- 2023: 56.09
- 2022: 28.82
- 2021: 31.94
Crestchem Ltd demonstrates strong profitability and efficient capital utilization.
Crestchem Ltd Ratios Analysis Summary
The Crestchem Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Crestchem Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Crestchem Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800